NNC 45-0095

NNC 45-0095是一種含氮有機化合物，化學式C₁₈H₁₇NO，可作為非甾體選擇性雌激素受體調節物（SERMs），由諾和諾德開發，用於治療骨質疏鬆症，從未上市銷售。^{[1][2][3][4][5]}

NNC 45-0095

臨床資料
其他名稱	NNC-450095
藥物類別（英語：Drug class）	選擇性雌激素受體調節物
識別資訊
IUPAC命名法 4-(1-ethylpyrrolo[2,1,5-cd]indolizin-2-yl)phenol
CAS號	217318-90-6
PubChem CID	9903336
ChemSpider	8078990
UNII	IS4M82C29X
ChEMBL	ChEMBL420017
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID60432621
化學資訊
化學式	C18H15NO
摩爾質量	261.32 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像
SMILES CCC1=C(C2=CC=C3N2C1=CC=C3)C4=CC=C(C=C4)O
InChI InChI=1S/C18H15NO/c1-2-15-16-5-3-4-13-8-11-17(19(13)16)18(15)12-6-9-14(20)10-7-12/h3-11,20H,2H2,1H3 Key:GBHFDPQPLXKNIU-UHFFFAOYSA-N

參考文獻

1. Jørgensen AS, Jacobsen P, Christiansen LB, Bury PS, Kanstrup A, Thorpe SM, et al. Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd] indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor. Bioorganic & Medicinal Chemistry Letters. February 2000, 10 (4): 399–402. PMID 10714509. doi:10.1016/S0960-894X(00)00015-9.
2. Sharma V, Kumar V. Indolizine: a biologically active moiety. Medicinal Chemistry Research. 2014, 23 (8): 3593–3606. ISSN 1054-2523. S2CID 2643469. doi:10.1007/s00044-014-0940-1.
3. Wallace OB, Richardson TI, Dodge JA. Estrogen receptor modulators: relationships of ligand structure, receptor affinity and functional activity. Current Topics in Medicinal Chemistry. 2003, 3 (14): 1663–1682. PMID 14683521. doi:10.2174/1568026033451727.
4. Meegan MJ, Lloyd DG. Understanding the Molecular Mechanism of Action of Estrogen Receptor Modulators. Frontiers in Medicinal Chemistry-Online. Atta-ur-Rahman, Reitz AB (編). Frontiers in Medicinal Chemistry 2. Bentham Science Publishers. January 2005: 183–231 (206). ISBN 978-1-60805-205-9. |issue=被忽略 (幫助)
5. NNC 450095. AdisInsight. Springer Nature Switzerland AG. [2024-01-18]. （原始內容存檔於2024-01-18）.